Other Definition. For the purposes of this Agreement, the terms listed below have the meanings ascribed to them in the respective sections of this Agreement set forth below. Accessed Party Section 4.03(a) Accessing Party Section 4.03(a) Acquired Companies Recitals Acquisition Section 1.02(c) Acquisition Engagement Section 9.16(a) Agreement Preamble Announcement Section 5.05 Anticipated Business Employees Section 2.27(a) Applicable Acquired ROW Equity Interests Section 1.03 Assumed Indebtedness Section 5.13(a) Benefits/Burdens Period Section 1.09(b) Business Financial Information Section 2.10(a) Business Financial Information Date Section 2.10(b) Business Intellectual Property Section 2.14(b) Business Interests Annex A Business Internal Reorganization Section 5.03 Business Key Customers Section 2.17 Business Key Suppliers Section 2.17 Business Material Contracts Section 2.16(b) Business Registered Intellectual Property Section 2.14(a) Business Transfer Documents Section 5.21 Buyer Preamble Buyer Acquisition Engagement Section 9.17(a) Buyer Aggregate Cap Section 8.04(b)(ii) Buyer Basket Amount Section 8.04(b)(iv) Buyer Board Recitals Buyer Counsel Section 9.17(a) Buyer De Minimis Amount Section 8.04(b)(iv) Buyer Debt Amount Section 6.03(f) Buyer General Cap Section 8.04(b)(ii) Buyer Indemnitees Section 8.02 Buyer Intellectual Property Section 3.12(b) Buyer Material Contracts Section 3.14(b) Buyer Parent Equity Financing Letter Recitals Claim Section 8.04(a) Closing Section 1.01 Closing Date Section 1.01 Closing Statement Section 1.06(b) Confidentiality Agreement Section 4.03(c) Consideration Allocation Schedule Section 1.03 Credit Support Items Section 5.15 Debt Financing Section 5.13(a) Dedicated Business Employees Section 4.03(d) Delayed Transfer Company Section 1.09(d) Direct Claim Section 8.06 Disclosing Party Section 5.04(b) DPA Section 2.20 Enforceability Exceptions Section 2.02(a) Equity Financing Letters Recitals Estimated Allocation Schedule Section 1.03 Estimated Assumed Indebtedness Amount Section 1.06(a) Estimated Closing Collaboration Adjustment Amount Section 1.06(a) Estimated Working Capital Adjustment Amount Section 1.06(a) Exclusion Right Section 1.10(b) Exclusion Right Exercise Date Section 1.10(b) Exclusivity Period Section 5.01 Existing Counsel Section 9.16(a) FCPA Section 2.19(a) Financing Section 5.13(a) Foreign Antitrust Approvals Section 5.02(a)(ii) Foreign Antitrust Laws Section 2.07(b) Future Cash Consideration Section 1.05(b) HSR Act Section 2.07(b) HSR Approval Section 5.02(a)(i) ICC Rules Section 9.13(a) Indemnified Party Section 8.04(a) Indemnifying Party Section 8.04(a) Independent Adjustment Expert Section 1.06(c) Independent Valuation Expert Section 5.02(e)(i) Information Security Reviews Section 2.14(l) Intended Irish Tax Treatment Section 5.06(a)(iii) Intended Tax Treatment Section 5.06(a)(iii) Intended U.S. Tax Treatment Section 5.06(a)(iii) Ireland Companies Act Section 3.11(f) Irish Acquired Company Recitals Irish Acquisition Section 1.02(c) Irish Estimated Closing Cash Consideration Section 1.03 Irish Future Cash Payment Section 1.05(a) Irish Future Cash Payment Conditions Section 1.05(a) Irish Redemption Section 1.02(c) Irish Seller Recitals Irish Spin-Off Recitals Irish Subscription Section 1.02(b) Labor Actions Section 2.27(b) Law Section 2.07(a) Legal Impediment Section 1.09(b) Legal Impediment Delayed Asset/Liability Section 1.09(b) Legal Impediment Delayed Assets/Liabilities Section 1.09(b) Legal Impediment Delayed Transfer Section 1.09(b) Legal Impediment Delayed Transfer Date Section 1.09(b) Licensed Business IP Contracts Section 2.14(c) Licensed Buyer IP Contracts Section 3.12(c) Liens Section 2.07(a) Mylan Ireland Recitals Notice of Disagreement Section 1.06(c) Order Section 2.07(a) Other Approvals Section 5.02(a)(iii) Outside Date Section 7.01(b)(i) Parties Preamble Regulatory Approvals Section 5.02(a)(iii) Requesting Party Section 5.04(b) Required Payments Section 3.21(c) Restraints Section 6.01(c) Retained Names Materials Section 5.07 Retained Records Annex A ROW Acquired Company Recitals ROW Acquisition Section 1.02(a) ROW Estimated Closing Cash Consideration Section 1.03 ROW Future Cash Payment Section 1.05(b) ROW Seller Recitals Seller Aggregate Cap Section 8.04(b)(i) Seller Basket Amount Section 8.04(b)(iii) Seller De Minimis Amount Section 8.04(b)(iii) Seller General Cap Section 8.04(b)(i) Seller Indemnitees Section 8.03 Seller Parent Preamble Seller Parent Board Recitals Seller Privileges Section 9.16(b) Sellers Recitals Serum Equity Financing Letter Recitals SHA Joinder Recitals Solvent Section 3.21(d) Specified Assets Section 1.10(b)(i) Specified Courts Section 9.12(b) Specified Liabilities Section 1.10(b)(ii) Specified Product Section 1.10(b)(iii) Specified Product Section 1.10(b)(iii) Stock Rights Section 2.03(c) Third Party Claim Section 8.05(a) Transferred Business Records Annex A Transferred Contracts Annex A Transferred IP Annex A Transferred IP Licenses Annex A Transferred Labeling and Marketing Materials Annex A Transferred Organizational Records Annex A Transition Period Section 5.07 TSA Delayed Asset Section 1.09(a) TSA Delayed Transfer Section 1.09(a) TSA Delayed Transfer Date Section 1.09(a) UKBA Section 2.19(a) Underlying Buyer Common Stock Section 3.03(b) Voting Debt Section 2.03(c) Written Consent Recitals
Appears in 1 contract
Sources: Transaction Agreement (Viatris Inc)
Other Definition. For the purposes of this Agreement, the terms listed below have the meanings ascribed to them in the respective sections of this Agreement set forth below. Accessed Party Access Limitations Section 4.03(a) Accessing Party Section 4.03(a4.02(a) Acquired Companies Recitals Acquired Company Recitals Acquisition Section 1.02(c) Acquisition Engagement 1.02 Affiliate Arrangements Section 9.16(a) 2.26 Agreement Preamble Announcement Section 5.05 Anticipated Business Employees Anti-Money Laundering Laws Section 2.27(a2.21(c) Applicable Acquired ROW Equity Interests Antitrust Approvals Section 1.03 Assumed Indebtedness Section 5.13(a5.01(a)(i) Asset Buying Entities Recitals Asset Buying Entity Recitals Asset Selling Entities Recitals Asset Selling Entity Recitals Benefits/Burdens Period Section 1.09(b1.08(c) Business Cash Annex A Business Financial Information Section 2.10(a2.09(a) Business Financial Information Date Insurance Policies Section 2.10(b) 5.14 Business Intellectual Property Section 2.14(b2.16(e) Business Interests Annex A Business Internal Reorganization Section 5.03 5.03(a) Business Inventory Statement Section 2.23(b) Business Key Customers Section 2.17 2.19 Business Key Suppliers Section 2.17 2.19 Business Material Contracts Section 2.16(b) Business Registered Intellectual Property Section 2.14(a2.18(b) Business Transfer Documents Section 5.21 Buyer Preamble Buyer Acquisition Engagement Section 9.17(a) Buyer Aggregate Cap Section 8.04(b)(ii) Buyer Basket Amount Section 8.04(b)(iv) Buyer Board Recitals 5.19 Buyer Counsel Section 9.17(a) 9.09 Buyer De Minimis Amount Section 8.04(b)(iv) Buyer Debt Amount Deductible Section 6.03(f8.04(b)(iv) Buyer Defined Benefit Plans Section 5.02(i) Buyer Engagement Section 9.16(a) Buyer General Cap Section 8.04(b)(ii8.04(b)(iii) Buyer Indemnitees Section 8.02 Buyer Parent Preamble Buyer Parties Preamble Buyer Party Preamble Buyer Released Parties Section 5.22 Buyer Retained Licensed Intellectual Property Section 3.12(b5.09(b)(iii) Buyer Material Contracts Section 3.14(b) Buyer Parent Equity Financing Letter Warranties Article III Buying Entities Recitals Claim Section 8.04(a) ▇▇▇▇▇▇▇▇ Section 9.09 Closing Section 1.01 Closing Date Section 1.01 Closing Statement Section 1.06(b1.05(b) Collective Bargaining Agreement Section 2.15(c) Commingled Contract Separation Section 5.20 Conditional Offer Section 5.02(a) Confidentiality Agreement Section 4.03(c4.02(b) Consideration Allocation Schedule Section 1.03 Credit Support Items Section 5.15 5.17 Data Privacy Requirements Section 2.16(n) Data Room Section 9.04 Debt Financing Section 5.13(a3.07(a) Dedicated Business Employees Debt Financing Commitment Section 4.03(d5.16(b) Debt Financing Commitments Section 3.07(a) Debt Financing Sources Section 3.07(a) Delayed Transfer Company Section 1.09(d1.08(e) Direct Claim Section 8.06 Disclosing Party Section 5.04(b) DPA Section 2.20 Enforceability Exceptions Section 2.02(a2.02 Equity Buying Entities Preamble Equity Buying Entity Preamble Equity Financing Section 3.07(a) Equity Financing Letters Recitals Commitment Section 3.07(a) Equity Financing Sources Section 3.07(a) Equity Selling Entities Preamble Equity Selling Entity Preamble Estimated Asset Allocation Schedule Section 1.03 Estimated Assumed Indebtedness Amount Section 1.06(a1.03(b) Estimated Closing Collaboration Adjustment Amount Cash Section 1.06(a1.05(a) Estimated Closing Indebtedness Section 1.05(a) Estimated Closing Statement Section 1.05(a) Estimated Working Capital Adjustment Amount Section 1.06(a1.05(a) Exclusion Right Excluded Intellectual Property Annex B Excluded Product Liabilities Annex D Filings Section 1.10(b2.06(b) Exclusion Right Exercise Date Final Asset Allocation Schedule Section 1.10(b1.03(c) Exclusivity Period Final Report Section 5.01 Existing Counsel Section 9.16(a) FCPA Section 2.19(a1.05(b) Financing Section 5.13(a3.07(a) Foreign Antitrust Approvals Financing Commitments Section 5.02(a)(ii3.07(a) Foreign Antitrust Laws Financing Sources Section 2.07(b3.07(a) Future Cash Consideration Forfeited Equity Awards Section 1.05(b5.02(e) HSR Act French Acquired Companies Recitals French Equity Buying Entity Preamble French RE Transfer Taxes Section 2.07(b8.02 French Reorganization Transfer Taxes Section 8.02 Impact CP Section 6.02(f) HSR Approval Inactive Employees Section 5.02(a)(i) ICC Rules Section 9.13(a5.02(a) Indemnified Party Section 8.04(a) Indemnifying Party Section 8.04(a) Independent Adjustment Expert Section 1.06(c1.05(b) Independent Valuation Allocation Expert Section 5.02(e)(i1.03(c) Information Security Reviews Insurance Policies Section 2.14(l2.20 Integration Plans Section 5.18(b)(i) Intended Irish Tax Treatment Inventory Count Section 5.06(a)(iii) Intended Tax Treatment Section 5.06(a)(iii) Intended U.S. Tax Treatment Section 5.06(a)(iii) Ireland 1.09 Italian Acquired Companies Act Section 3.11(f) Irish Acquired Company Recitals Irish Acquisition Section 1.02(c) Irish Estimated Closing Cash Consideration Section 1.03 Irish Future Cash Payment Section 1.05(a) Irish Future Cash Payment Conditions Section 1.05(a) Irish Redemption Section 1.02(c) Irish Seller Recitals Irish Spin-Off Recitals Irish Subscription Section 1.02(b) Labor Actions Section 2.27(b) Law Section 2.07(a) Italian Equity Buying Entity Preamble Italian Equity Selling Entity Preamble Legal Impediment Section 1.09(b1.08(a) Legal Impediment Delayed Asset/Liability Section 1.09(b1.08(a) Legal Impediment Delayed Assets/Liabilities Section 1.09(b1.08(a) Legal Impediment Delayed Transfer Section 1.09(b1.08(b) Legal Impediment Delayed Transfer Date Section 1.09(b1.08(b) Legal Restraint Section 6.01(c) Licensed Business IP Contracts Trademarks Section 2.14(c) Licensed Buyer IP Contracts Section 3.12(c5.10(c)(i) Liens Section 2.07(a2.06(a) Mylan Ireland Recitals Material Tax Dispute Section 5.06(g) Measurement Date Section 5.02(e) Meda Holding Section 1.04(b)(i) Notice of Disagreement Section 1.06(c) Order Section 2.07(a1.05(b) Other Approvals Section 5.02(a)(iii5.01(a)(ii) Outside Date Section 7.01(b)(i) Parties Preamble Party Preamble Preliminary Report Section 1.05(b) Prepaid Amounts Annex A Product Liabilities Annex C Proprietary Software Section 2.16(i) Provisional Allocation Section 1.03(a) Put Date Recitals Put Option Agreement Recitals Real Property Annex A Real Property Lease Annex A Recipient Section 5.06(a)(ii) Registered Intellectual Property Section 2.16(a) Regulatory Approvals Section 5.02(a)(iii5.01(a)(ii) Related Person Section 2.26 Remedial Action Section 2.17(d) Requesting Party Section 5.04(b) Required Payments Restricted Activity Section 3.21(c5.11(b) Restraints Retained Names Health Care Approval Section 6.01(c5.10(d)(ii)(B) Retained Names Inventory Section 5.10(d)(ii)(A) Retained Names Inventory Transition Period Section 5.10(d)(ii) Retained Names Materials Section 5.07 5.10(d)(i) Retained Names Materials Transition Period Section 5.10(d)(i) Retained Records Annex A ROW Acquired Company Recitals ROW Acquisition Retained Rights Section 1.02(a) ROW Estimated Closing Cash Consideration Section 1.03 ROW Future Cash Payment Section 1.05(b) ROW Seller Recitals Seller Aggregate Cap Section 8.04(b)(i) Seller Basket Amount Section 8.04(b)(iii) 5.22 Seller De Minimis Amount Section 8.04(b)(iii8.04(b)(ii) Seller Deductible Section 8.04(b)(ii) Seller Defined Benefit Plans Section 5.02(i) Seller Engagement Section 9.15(a) Seller General Cap Section 8.04(b)(i) Seller Indemnitees Section 8.03 Seller Non-Spring Territory Products Section 5.09(b)(ii) Seller Parent Preamble Seller Parent Board Recitals Parties Preamble Seller Party Preamble Seller Prepared Tax Returns Section 5.06(g) Seller Privileges Section 9.16(b9.15(b) Sellers Seller Releasing Parties Section 5.22 Seller Retained Licensed Intellectual Property Section 5.09(a) Seller Return Due Date Section 5.06(g) Seller Spring Territory Rx Products Section 5.09(b)(i) Seller Warranties Article II Selling Entities Recitals Serum Equity Financing Letter Recitals SHA Joinder Recitals Solvent Signing Date Preamble ▇▇▇▇▇▇▇ Section 3.21(d9.09 Specifically Assumed Environmental Liabilities Annex C Specifically Assumed Real Property Liabilities Annex C Specified Tax Contest Section 5.06(h) Specified Assets Statutory Accounts Section 1.10(b)(i) Specified Courts Section 9.12(b) Specified Liabilities Section 1.10(b)(ii) Specified Product Section 1.10(b)(iii) Specified Product Section 1.10(b)(iii2.09(c) Stock Rights Section 2.03(c2.03(b) Supplier Section 5.06(a)(ii) Swedish Equity Selling Entity Preamble Third Party Claim Section 8.05(a) Third-Party Consents Section 5.27(a) Trade Name Section 2.25 Transfer Date Section 5.02(a) Transfer Plan Section 5.18(b)(i) Transferred Business Records Annex A Transferred Contracts Annex A Transferred IP Defined Benefit Plan Participants Section 5.02(i) Transferred Employee Section 5.02(a) Transferred Employee Equity Award Section 5.02(e) Transferred Equipment Annex A Transferred Intellectual Property Annex A Transferred IP Licenses Annex A Transferred IT Annex A Transferred Labeling and Marketing Materials Annex A Transferred Leased Real Property Annex A Transferred Organizational Records Annex A Transition Period Transferred Owned Real Property Annex A Transitional Plan Section 5.07 TSA Delayed Asset Section 1.09(a5.18(b)(i) TSA Delayed Transfer Fee Payment Section 1.09(a) TSA Delayed Transfer Date Section 1.09(a) UKBA Section 2.19(a) Underlying Buyer Common Stock Section 3.03(b1.04(a)(vii) Voting Debt Section 2.03(c2.03(b) Written Consent RecitalsWillkie Section 9.09
Appears in 1 contract
Sources: Transaction Agreement (Viatris Inc)